FDA Commissioner Scott Gottlieb Joins Pfizer Board After Leaving Agency

| Importance: 8/10 | Status: confirmed

Scott Gottlieb, former FDA Commissioner, joined Pfizer’s board of directors on June 27, 2019, just 85 days after leaving the FDA. The move sparked significant criticism about the ‘revolving door’ between government regulatory agencies and pharmaceutical companies. Gottlieb will serve on the board’s regulatory and compliance committee, raising concerns about potential conflicts of interest in drug approval processes.

Key Actors

Scott Gottlieb Elizabeth Warren Pfizer Board of Directors Food and Drug Administration

Tags

regulatory-capture pharmaceutical-industry revolving-door fda conflict-of-interest

Sources (3)

Help Improve This Timeline

Found an error or have additional information? You can help improve this event.

✏️ Edit This Event ➕ Suggest New Event

Edit: Opens GitHub editor to submit corrections or improvements via pull request.
Suggest: Opens a GitHub issue to propose a new event for the timeline.